This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

REPEVAX®

diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content)

Profile

REPEVAX® is a 4-in-1 vaccine indicated for active immunisation against diphtheria, tetanus, pertussis and poliomyelitis (polio) in persons from 3 years of age as a booster following primary immunisation and for passive protection against pertussis in early infancy following maternal immunisation.

Before you prescribe this vaccine please refer to the SmPC.1

 

 

Ways to order

You can order REPEVAX Vaccines through VAXISHOP. Read more about ordering vaccines.

References
  1.  REPEVAX® Summary of Product Characteristics.

MAT-XU-2301125 (v3.0) Date of preparation: October 2023